Skip to main content
OGN logo

OGN · Organon & Co. · Metrics

Track OGN — free
Market Cap
$3.65B
Shares
262.62M
Volume · Nov 17 4.16M Avg daily vol (3M) 2.71M

OGN metrics

105 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.90
Market cap
$3.65B

Price action

23 metrics
Price change (1W)
+0.1%
Price change (30D)
+1.1%
Price change (3M)
+1.6%
Price change (6M)
+3.6%
Price change (YTD)
+93.9%
Price change (1Y)
+81.7%
Trailing year
Price change (5Y)
-57.8%
52-week high
$13.90
52-week low
$5.70
Change from 52-week high
+0.0%
Change from 52-week low
+143.9%
Annualized volatility
58.2%
Annualized volatility (3M)
3.0%
Implied volatility (30D)
9.7%
IV rank (1Y)
0.5
IV percentile (1Y)
0.7
Beta
0.6
RSI (14D)
65.8
Price vs SMA 50
+1.0%
Price vs SMA 200
+17.7%
Avg volume (3M)
2.71M
Relative volume
1.5
Average dollar volume
$37.24M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
262.62M

Valuation

12 metrics
P / E (TTM)
18.1
Trailing earnings · reciprocal yield 5.5%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 56.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 167.1%
P / book
3.1
reciprocal yield 32.7%
FCF yield
18.5%
TTM · current market cap
Buyback yield
—
P / FCF
5.4
reciprocal yield 18.5%
P / operating cash flow
4.3
reciprocal yield 23.1%
Earnings yield
5.8%

Historical valuation

8 metrics
P / E historical average (3Y)
7.6×
reciprocal yield 13.1%
P / E historical average (5Y)
7.4×
reciprocal yield 13.4%
EV / revenue historical average (3Y)
1.8×
reciprocal yield 54.5%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 48.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.7%
Trailing 12 months
Payout ratio
9.4%
Shareholder yield
0.5%
Dividend / share (TTM)
$0.10
Dividend growth YoY
-68.8%
Dividend growth streak
0
Last ex-dividend
2026-11-09

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-04-30

Profitability

9 metrics
Gross margin
53.1%
Operating margin
—
Trailing 12 months
Net margin
3.5%
Gross profit (TTM)
$3.24B
Operating profit (TTM)
—
Net income (TTM)
$213.00M
Trailing 12 months
Diluted EPS (TTM)
$0.77
FCF margin
11.1%
Effective tax rate
57.7%

Per share

11 metrics
Revenue per diluted share (TTM)
$22.86
Gross profit per diluted share (TTM)
$12.14
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.77
Operating cash flow per diluted share (TTM)
$3.15
Free cash flow per diluted share (TTM)
$2.52
Capital expenditures per diluted share (TTM)
$0.63
R&D per diluted share (TTM)
$1.34
Stock compensation per diluted share (TTM)
$0.27
Book value per share
$2.89

Growth

11 metrics
Revenue growth YoY
-1.7%
Year over year
Net income growth YoY
+2.5%
Revenue (TTM)
$6.10B
Trailing 12 months
EPS growth YoY
-1.6%
Shares change YoY
+4.5%
Year over year · more shares
Revenue CAGR (3Y)
+0.2%
Revenue CAGR (5Y)
-1.0%
EPS CAGR (3Y)
-41.5%
EPS CAGR (5Y)
-39.0%
FCF CAGR (3Y)
-6.7%
FCF CAGR (5Y)
-23.3%

Quality

14 metrics
Return on equity
17.9%
Return on assets
1.6%
Debt / equity
7.2
Current ratio
2.0
EBITDA (TTM)
—
Free cash flow (TTM)
$675.00M
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$7.10B
Latest balance sheet
Cash & equivalents
$1.46B
Total assets
$13.40B
Total debt
$8.55B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$843.00M
Capital expenditures (TTM)
$168.00M
R&D (TTM)
$357.00M
SG&A (TTM)
$1.71B
Stock compensation (TTM)
$72.00M
R&D / revenue
5.9%
Stock compensation / revenue
1.2%

Ownership (13F)

9 metrics
13F filers
607
13F filer change QoQ
-34
Institutional ownership
86.1%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
31.9%
Private-fund adviser ownership
26.0%
Active holders' share change QoQ
+6.3%
Holder tenure
9.8
Price vs estimated holder cost
-16.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.1%

Short interest

3 metrics
Short interest
7.5%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1821825 CUSIP 68622V106 13F (30d) 642 filings 554 filers Visit website Investor relations